F M Investments LLC Sells 20,971 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

F M Investments LLC decreased its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 14.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 125,043 shares of the medical instruments supplier's stock after selling 20,971 shares during the period. F M Investments LLC owned 0.22% of Merit Medical Systems worth $12,358,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MMSI. Norden Group LLC bought a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $293,000. Sequoia Financial Advisors LLC bought a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $336,000. BNP Paribas Financial Markets raised its position in shares of Merit Medical Systems by 55.3% during the first quarter. BNP Paribas Financial Markets now owns 52,953 shares of the medical instruments supplier's stock valued at $4,011,000 after buying an additional 18,863 shares during the last quarter. Fidelis Capital Partners LLC bought a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $90,000. Finally, FORA Capital LLC bought a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $577,000. Institutional investors own 99.66% of the company's stock.

Wall Street Analysts Forecast Growth

MMSI has been the topic of several recent analyst reports. Needham & Company LLC reiterated a "buy" rating and set a $109.00 price objective on shares of Merit Medical Systems in a research report on Thursday. StockNews.com upgraded shares of Merit Medical Systems from a "hold" rating to a "buy" rating in a research report on Saturday, October 26th. Robert W. Baird raised their target price on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an "outperform" rating in a report on Thursday. Bank of America raised their target price on shares of Merit Medical Systems from $92.00 to $103.00 and gave the company a "neutral" rating in a report on Monday, September 16th. Finally, Wells Fargo & Company raised their target price on shares of Merit Medical Systems from $85.00 to $103.00 and gave the company an "equal weight" rating in a report on Monday, September 16th. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Merit Medical Systems has an average rating of "Moderate Buy" and an average target price of $103.36.

Merit Medical Systems Trading Up 0.1 %

NASDAQ MMSI traded up $0.14 on Friday, hitting $98.80. 392,724 shares of the stock were exchanged, compared to its average volume of 353,393. The company has a debt-to-equity ratio of 0.57, a quick ratio of 4.64 and a current ratio of 5.36. The stock has a fifty day moving average price of $96.60 and a two-hundred day moving average price of $87.99. The firm has a market capitalization of $5.76 billion, a P/E ratio of 48.43, a P/E/G ratio of 2.45 and a beta of 0.89. Merit Medical Systems, Inc. has a 52-week low of $65.46 and a 52-week high of $101.60.

Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The medical instruments supplier reported $0.86 EPS for the quarter, topping the consensus estimate of $0.80 by $0.06. The company had revenue of $339.85 million during the quarter, compared to analyst estimates of $334.60 million. Merit Medical Systems had a net margin of 9.05% and a return on equity of 15.61%. Merit Medical Systems's quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 earnings per share. Research analysts forecast that Merit Medical Systems, Inc. will post 3.36 EPS for the current fiscal year.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.